{"id":18,"date":"2024-10-16T15:30:06","date_gmt":"2024-10-16T13:30:06","guid":{"rendered":"http:\/\/metacrystal.ch\/?page_id=18"},"modified":"2025-07-16T14:38:00","modified_gmt":"2025-07-16T12:38:00","slug":"about-us","status":"publish","type":"page","link":"https:\/\/metacrystal.ch\/?page_id=18","title":{"rendered":"About us"},"content":{"rendered":"\n

Executive board<\/h2>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Prof. Paul Lecoq<\/a>, Chairman & CEO<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Georgios Kostantinou<\/a>, CTO<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Catherine Lef\u00e8vre<\/a>, CFO & Business Manager<\/p>\n<\/div>\n<\/div>\n\n\n\n

Scientific advisory board<\/h2>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Jos\u00e9 Mar\u00eda Benlloch<\/a>, Chairman<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Chi-Hua Tung<\/a>, member<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Antonio J. Gonz\u00e1lez<\/a>, member<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

John Prior<\/a>, member<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Paul Schotanus<\/a>, member<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Virginia Spanoudaki<\/a>, member<\/p>\n<\/div>\n<\/div>\n\n\n\n

\n\n\n\n

Prof. Paul Lecoq, PhD, Chairman of the Board & CEO<\/strong><\/p>\n\n\n\n

    \n
  • Graduated as Engineer in Physics Instrumentation at the Ecole Polytechnique of Grenoble under the leadership of Nobel Laureate Louis N\u00e9el<\/li>\n\n\n\n
  • PhD in Nuclear Physics (Nuclear Physics Laboratory of the University of Montreal, Canada)<\/li>\n\n\n\n
  • Head of Physics Division at the European Academy of Sciences<\/li>\n\n\n\n
  • Doctor Honoris Causa at the Polytechnic University of Valencia, Spain<\/li>\n\n\n\n
  • Doctor Honoris Causa at the Kharkhiv Institute of Single Crystals (Ukraine Academy of Sciences)<\/li>\n\n\n\n
  • Founder of the Crystal Clear Collaboration & of CERIMED (European Center for Research in Medical Imaging)   <\/li>\n<\/ul>\n\n\n\n

    Paul dedicated his 40 year career to the field of medical physics at CERN, the European Organization for Nuclear Research.<\/p>\n\n\n\n

    His work on particle physics detectors focused on applications in medical imaging. His research findings continue to inspire several groups around the world working on improving the sensitivity and performance of PET scanners. His work on detector instrumentation and particularly on heavy inorganic scintillator materials has received strong support from Nobel Laureates, Carlo Rubia and Georges Charpak. While at CERN, his work played an important role in the discovery of the Higgs boson.<\/p>\n\n\n\n

    In 2019, Paul became co-CEO of a newly created subsidiary of Multiwave Technologies SA. In 2024, he leaded the spin off of METACRYSTAL SA (formerly called Multiwave Metacrystal SA) and became CEO.<\/p>\n\n\n\n

    Georgios Konstantinou, PhD, CTO & member of the Board<\/strong><\/p>\n\n\n\n

      \n
    • Diploma in electronic engineering at National Technical University of Athens<\/li>\n\n\n\n
    • PhD in Medical Physics at Universidad Carlos III Madrid<\/li>\n\n\n\n
    • Marie Sklodowska Curie grant<\/li>\n<\/ul>\n\n\n\n

      Georgios started his career in 2009 at CERN, developing electronics for both low-level RF control for the proton synchrotron, the accelerator feeding particles to the LHC, as well as for the straw tracker of the ultra-rare kaon experiment NA62.<\/p>\n\n\n\n

      Being interested in all aspects of technology, Georgios spent a year as a patent examiner at the European Patent Office.<\/p>\n\n\n\n

      He left EPO to found his own startup, SensYnc, in 2019 on the development of a commercial PET system. <\/p>\n\n\n\n

      Georgios joined Multiwave Metacrystal SA as CTO after the acquisition of SensYnc by Multiwave Metacrystal SA. At Multiwave Metacrystal, Georgios leads the analysis, testing and development of metamaterial-based ultra-fast block detectors for positron emission tomography.<\/p>\n\n\n\n

      Georgios participated in the European Institute for Innovation and Technology Healthcare network.<\/p>\n\n\n\n

      Catherine Lef\u00e8vre, CFO, Business Manager & member of the Board<\/strong><\/p>\n\n\n\n

        \n
      • Graduated as Engineer at the Ecole Nationale de l’Aviation Civile in Toulouse, France<\/li>\n\n\n\n
      • Graduated from Institut d’Etudes Politiques (Economy & Finance) in Paris, France<\/li>\n<\/ul>\n\n\n\n

        After having held positions in the banking sector, Catherine served in mid-cap companies as CFO & Secretary-general. She is presently an independent consultant in business development and operational strategy. She is member of several board of directors. <\/p>\n\n\n\n

        Jos\u00e9 Mar\u00eda Benlloch, Chairman of the Scientific Advisory Board<\/strong><\/p>\n\n\n\n

          \n
        • PhD in Nuclear Physics (DELPHI collaboration of the LEP accelerator at CERN)<\/li>\n\n\n\n
        • Full Professor at the Spanish National Research Council (CSIC)<\/li>\n\n\n\n
        • Founder and Director of the Institute for Instrumentation of Molecular Imaging (I3M) at the Polytechnic University of Valencia, Spain<\/li>\n\n\n\n
        • Received from Felipe VI, King of Spain, the National Research Award \u00ab\u00a0Leonardo Torres Quevedo\u00a0\u00bb in 2014, and from Juan Carlos I, former King of Spain, the \u00ab\u00a0Rey Jaime I\u00a0\u00bb award in 2008.<\/li>\n<\/ul>\n\n\n\n

          Jos\u00e9 Mar\u00eda worked in particle detectors at CERN (Geneva, Switzerland and at the Fermi National Accelerator Laboratory (Chicago, USA).<\/p>\n\n\n\n

          Later, he was member of the CDF collaboration that discovered in 1995 the top quark, one of the 12 elementary particles. He worked as Staff member of the Massachussetts Institute of Technology under the direction of Jerome Friedman (Nobel Laureate in Physics, 1990).<\/p>\n\n\n\n

          In 1996, Jos\u00e9 Mar\u00eda came back to CERN in order to perform research on radiation detectors in the groups of F. Sauli and T. Ypsilantis. When he returned to Spain in 1999, he started a research group on Medical Imaging. Since then, he has developed several medical imaging diagnostic devices based on the detection of gamma rays, X-rays, and magnetic resonance.<\/p>\n\n\n\n

          Author of around 300 articles in international peer reviewed publications. Advisor of 10 PhD theses. Author of more than 20 patents related to imaging equipment for medical diagnosis.<\/p>\n\n\n\n

          Chi-Hua Tung, member of the Scientific Advisory Board<\/strong><\/p>\n\n\n\n

          After receiving a Ph.D. degree, Chi Hua Tung started his professional career in nuclear medicine instrumentation. He was employed first by Trionix  in SPECT systems. After a year he joined Philips Healthcare to work on both SPECT and PET systems. <\/p>\n\n\n\n

          In the 20+ year with Philips, his roles and responsibilities spanned from physicist, system engineer, application engineer, product manufacturing engineer, manager of reconstruction, and director of advanced developments.<\/p>\n\n\n\n

          Chi Hua has very broad and in-depth knowledge of the lifecycle of hybrid nuclear medicine systems: SPECT\/CT, PET\/CT, PET\/MR, including design, development, manufacturing, quality and service. After his retirement in 2018 from Philips, he has being working as a consultant to assist Taiwanese government, companies, and investors who are interested in bringing the cutting-edge total-body PET and photo-counting CT development and manufacturing to Taiwan.<\/p>\n\n\n\n

          Antonio J. Gonz\u00e1lez, member of the Scientific Advisory Board<\/strong><\/p>\n\n\n\n

            \n
          • Physics Degree in 2002 at the University of Valencia<\/li>\n\n\n\n
          • PhD in 2005 at the University of Heidelberg in Germany : the work, entitled \u201cQuantum interference in the dielectronic recombination of heavy highly charged ions\u201d, was carried out at the Max Planck Institute for Nuclear Physics in Heidelberg.<\/li>\n<\/ul>\n\n\n\n

            Antonio is a researcher at the Spanish National Research Council (CSIC), with a permanent position since 2017, working on the development of molecular imaging systems since 2006.<\/p>\n\n\n\n

            Since about 2006, Antonio has built PET prototypes in the preclinical small animal field and also in the clinical site. He has made a concerted effort to focus on imagers using monolithic crystals. The devices developed have been successfully transferred to the industry such as the small animal PET Albira, currently distributed by Bruker, or the dedicated breast PET commercialized by Oncovision. Antonio has scientifically led two EU grants, the breast-dedicated PET MAMMI and currently the brain PET insert called MINDView. In 2020 He was awarded with two NIH projects namely an R01 as co-PI (1R01EB029450-01) and an R21 in collaboration with University of Washington (EB028420-01). In the first, a novel preclinical PET insert for 9T MRI has been constructed. In 2023 Antonio been awarded with another R01 as co-PI together with the Weill Medical Center at Cornell in NY. In 2022-2023 he managed the design and built of the first TB-PET with DOI and TOF capabilities, installed in Valencia (Spain). Very recently he has been awarded with a grant from the Valencian region to develop a PET scanner for dosimetry estimations after proton therapy.<\/p>\n\n\n\n

            He has over 100 peer-reviewed papers in high impact journals. Antonio has an h-index of 28. He has filled for 13 patents, most of them licenced. He has successfully directed 10 PhD theses and is currently supervising 5 more concerning about the design of a gamma ray detectors, eventually MR compatible.<\/p>\n\n\n\n

            John Prior, member of the Scientific Advisory Board<\/strong><\/p>\n\n\n\n

            Professor John Prior is head of department of nuclear medicine and molecular imaging at Lausanne University Hospital (CHUV) and a professor of nuclear medicine at the University of Lausanne<\/p>\n\n\n\n

            Paul Schotanus, member of the Scientific Advisory Board<\/strong><\/p>\n\n\n\n

            Dr. Paul Schotanus started his work on scintillation materials at the Delft University of Technology under Prof. Carel Van Eijk. His subject was the luminescence properties of barium fluoride applied to positron emission tomograpy . Later he worked on several projects at universities (University Utrecht, TU eindhoven) on the application of scintillation materials in various physics projects. His interest is the design and use of dedicated scintillation sensors in science, industry, medicine end security. He gives webinars, lectures and courses on the optimum use of scintillation crystals in all above mentioned fields and is managing director of SCIONIX Holland.<\/p>\n\n\n\n

            Virginia Spanoudaki, member of the Scientific Advisory Board<\/strong><\/p>\n\n\n\n

            Virginia is a physicist with over 20 years of experience in the development of non-invasive, imaging-based technologies and methodologies for evaluating disease and therapy. She holds a PhD in experimental physics from TUM with a focus on nuclear medicine technology and has completed her postdoctoral training at Stanford University where she focused on computational evaluation of radiation-based diagnostic technologies for clinical breast and full-body Time-of-Flight (ToF) imaging. After joining a team at Philips Research assisting with technology demonstration of digital photonics technologies, Virginia returned to academia in Robert Langer\u2019s group and Children\u2019s Hospital Boston, where she developed a multimodal portfolio of imaging-based approaches for the evaluation of drug delivery devices and explored nanoscale-based sensor technologies. For the latter, she spent time as a visiting scientist at CERN further exploring the applicability of radiation sensing at the nanoscale. Currently, she serves as the scientific director of one of MIT\u2019s shared technology labs, the Preclinical Imaging and Testing Facility (Preclinical I&T) at the Koch Institute for Integrative Cancer Research, that is responsible for an end-to-end in-vivo evaluation of novel therapies using imaging and computation as core technologies. Virginia has authored numerous peer reviewed publications, is an inventor on four patents and has consulted for biotechnology startups.<\/p>\n","protected":false},"excerpt":{"rendered":"

            Executive board Prof. Paul Lecoq, Chairman & CEO Georgios Kostantinou, CTO Catherine Lef\u00e8vre, CFO & Business Manager Scientific advisory board Jos\u00e9 Mar\u00eda Benlloch, Chairman Chi-Hua Tung, member Antonio J. Gonz\u00e1lez, member John Prior, member Paul Schotanus, member Virginia Spanoudaki, member Prof. Paul Lecoq, PhD, Chairman of the Board & CEO Paul dedicated his 40 year […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-18","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/metacrystal.ch\/index.php?rest_route=\/wp\/v2\/pages\/18","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/metacrystal.ch\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/metacrystal.ch\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/metacrystal.ch\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/metacrystal.ch\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=18"}],"version-history":[{"count":66,"href":"https:\/\/metacrystal.ch\/index.php?rest_route=\/wp\/v2\/pages\/18\/revisions"}],"predecessor-version":[{"id":1069,"href":"https:\/\/metacrystal.ch\/index.php?rest_route=\/wp\/v2\/pages\/18\/revisions\/1069"}],"wp:attachment":[{"href":"https:\/\/metacrystal.ch\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=18"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}